| Tag | Content |
|---|
EnhancerAtlas ID | HS091-16290 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr16:11012380-11013050 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr16:11012780-11012799 | CACTGCCACCTTCTGGTAG | - | 6.49 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09716 | chr16:11011665-11013016 | CD14 | | SE_10278 | chr16:11011406-11013112 | CD19_Primary |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I010918 | chr16 | 11012125 | 11013350 |
|
Enhancer Sequence | AAGGTGAGTG GGGCCCCGGA TACCGGTCAG GTGCTGAGCT GGGGGGCTGC AGAGCGCAGG 60
GAACCCACAT CGTGCTGGCT GCAGGGGACA CTGAGACCCT AGAAGCAATC ACCACAGCCC 120
TGAACAAAAG GATTAGCGGG ACGTGGTGAA AGAAACTCTG AGCAAGTCAG TTATTCATTC 180
CTAGCCGCTG TTTTCTTACC TGGAAAATGG GAACCATCCT AATGGTCTAT GTAAGCACTT 240
GTCACAATGC CAGGTTCTGT TATGCAATAA ATATTGCTCC TTTTCCCCCA GGGATGGCGG 300
GACCAGGCTT TTTCCGGAAC CTAGGGGTGG TGGCTTCTGG AAGGCTAACC ACGTACGTCA 360
GCTTTTGCCG GCCTTGTCAC TTACATGCCG GTCAGTGTTT CACTGCCACC TTCTGGTAGG 420
CCTTGGCATA GCACCTCTTG CTTTTGAGTG ACTTCCATCC AGGCCCTGGT GTGGTCCCAG 480
AGGTAATGAG CGGACTGAGC TTGGACCAGA GCCCCAGTCA TCCAACTCAG CATTACCAGC 540
TCTTCTTACT CGCCAGACTG AGAGAAACTG CTCTCCTCTT CGCCAGAGCT CTTCACTTAC 600
TGAGGACAAC CAGAGTCAGA TTCCCAGGAA AGATGGCATT TGGTCCCTTA TTATTTATTT 660
ATTTTTAATT 670
|
